We are live on ! Find out more
PARN

Parnell Pharmaceuticals Holdings Ltd
PARN

Delisted

PARN was delisted on the 30th of December, 2016.

Back to rankings

18 hedge funds and large institutions have $4.04M invested in Parnell Pharmaceuticals Holdings Ltd in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

5% less funds holding

Funds holding: 19 → 18 (-1)

12% less capital invested

Capital invested by funds: $4.61M → $4.04M (-$568K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BG
BlackRock Group
United Kingdom
+$28.2K
2
BlackRock
BlackRock
New York
+$25.1K
3
BIM
BlackRock Investment Management
Delaware
+$16.7K
4
Creative Planning
Creative Planning
Kansas
+$5.42K

Top Sellers

1
SM
Sabby Management
Florida
-$30.5K
2
LTFS
Ladenburg Thalmann Financial Services
Florida
-$19.3K
3
BA
BlackRock Advisors
Delaware
-$15.2K
4
UBS Group
UBS Group
Switzerland
-$7K
5
Goldman Sachs
Goldman Sachs
New York
-$928
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.18M – – –
BA
2
BlackRock Advisors
Delaware
$799K -$15.2K -9,800 -2%
ECM
3
Endurant Capital Management
California
$637K – – –
SM
4
Sabby Management
Florida
$532K -$30.5K -19,700 -5%
BG
5
BlackRock Group
United Kingdom
$334K +$28.2K +18,200 +8%
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
$209K – – –
BlackRock
7
BlackRock
New York
$144K +$25.1K +16,200 +19%
BIM
8
BlackRock Investment Management
Delaware
$104K +$16.7K +10,800 +17%
LTFS
9
Ladenburg Thalmann Financial Services
Florida
$35K -$19.3K -12,500 -34%
AP
10
Atwood & Palmer
Missouri
$24K – – –
Goldman Sachs
11
Goldman Sachs
New York
$15K -$928 -600 -5%
Cambridge Investment Research Advisors
12
Cambridge Investment Research Advisors
Iowa
$14K – – –
Creative Planning
13
Creative Planning
Kansas
$8K +$5.42K +3,500 +175%
Morgan Stanley
14
Morgan Stanley
New York
$6K – – –
AG
15
Advisor Group
Arizona
$2K – – –
AA
16
AlphaMark Advisors
Kentucky
$1K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$1K – – –
Walleye Trading
18
Walleye Trading
New York
$1K – – –
UBS Group
19
UBS Group
Switzerland
– -$7K -4,023 Closed

PARN Hedge Fund Activity: Q3 2016 in Review

18 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q3 2016, worth a combined $4.04M — down 12% from $4.61M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PARN and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.

The largest buyer was BlackRock Group, adding an estimated $28.2K. The largest seller was Sabby Management, cutting an estimated $30.5K.

  • 18 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q3 2016, down from 19 in Q2 2016.
  • Funds reported $4.04M of Parnell Pharmaceuticals Holdings Ltd stock for Q3 2016, down 12% quarter-over-quarter.
  • 0 funds opened new Parnell Pharmaceuticals Holdings Ltd positions in Q3 2016 and 1 closed out, a net change of -1 holder.
  • The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q3 2016 was BlackRock Group, an estimated $28.2K added.
  • The largest Parnell Pharmaceuticals Holdings Ltd seller in Q3 2016 was Sabby Management, an estimated $30.5K sold.

Based on aggregated 13F filings for Q3 2016.